U.S., Nov. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07251153) titled 'Pharmacokinetic Comparison of Vonafexor Acid and Its Lysine Salt and Evaluation of Potential Drug-Drug Interactions' on Nov. 14.
Brief Summary: The purpose of this study is to define and compare the pharmacokinetic (PK) and pharmacodynamic (PD) profile of EYP651 at two dose levels and compare it with Vonafexor Acid PK and PD profile, the Part A.
In addition, Part B of the trial will assess the Drug-Drug Interactions (DDI) potential with the high dose of EYP651.
Study Start Date: Oct. 28
Study Type: INTERVENTIONAL
Condition:
Healthy Adult Male and Female Volunteers
Intervention:
DRUG: EYP651/Vonafexor low dose
Repeated daily ...